Related Experiment Video
Updated: May 18, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients
Mehmet Kanbay1, Mahmut Ilker Yilmaz, Mugurel Apetrii
1Department of Nephrology, Gülhane School of Medicine, Ankara, Turkey.
Insights
Magnesium is vital for kidney health and may prevent heart disease in chronic kidney disease (CKD) patients. Lower magnesium levels are linked to increased cardiovascular mortality in CKD.
Area of Science:
- Nephrology
- Cardiology
- Biochemistry
Background:
- Magnesium is essential for cellular function and enzyme activity.
- Chronic kidney disease (CKD) patients face increased cardiovascular risk.
- The role of magnesium as a cardiovascular risk factor in CKD was previously unevaluated.
Purpose of the Study:
- To investigate magnesium as an independent cardiovascular risk factor in CKD patients.
- To assess the relationship between magnesium levels, endothelial function, and cardiovascular outcomes in CKD.
Main Methods:
- A cohort of 283 CKD patients was followed for cardiovascular events.
- Flow-mediated dilatation (FMD) and nitroglycerin-mediated dilatation were assessed using ultrasound.
- Time-to-event analysis and Cox proportional hazards models were employed.
Main Results:
- Higher magnesium levels correlated positively with FMD, indicating less endothelial dysfunction.
- Magnesium and estimated glomerular filtration rate (eGFR) were strong positive predictors of FMD.
- Low serum magnesium (<2.05 mg/dl) was associated with significantly higher cardiovascular mortality rates.
Conclusions:
- Magnesium may be an independent predictor of cardiovascular outcomes in CKD patients.
- This study is the first to demonstrate magnesium's role in cardiovascular risk across different stages of etiologically diagnosed CKD.
Background:
Magnesium is an essential ion for all living cells because over 300 enzymes require the presence of magnesium for their catalytic action. To date, no group has evaluated magnesium as a cardiovascular risk factor in chronic kidney disease (CKD) subjects, in which closely interrelated factors and potential confounders such as endothelial dysfunction, insulin resistance (the homeostasis model assessment (HOMA) index) and inflammation (expressed as serum C-reactive protein (CRP) levels) were also considered.
Methods:
Between March 2006 and December 2010, 283 CKD patients were followed up for time-to-event analysis until the occurrence of fatal or nonfatal cardiovascular events. Endothelium-dependent vasodilatation (flow-mediated dilatation; FMD) and endothelium-independent vasodilatation (nitroglycerin-mediated dilatation) of the brachial artery were assessed noninvasively using high-resolution ultrasound.
Results:
From the univariate analysis of FMD, it appears that a higher magnesium level is associated with less endothelial dysfunction. When a multivariate analysis was performed, magnesium and estimated glomerular filtration rates (eGFR) maintained a strong positive correlation with FMD, supporting the hypothesis that higher levels of magnesium may protect against endothelial damage. In univariate Cox proportional hazards models, FMD, magnesium, high sensitivity CRP, the HOMA index, eGFR, comorbid diabetes, hypertension, smoking status, systolic blood pressure, serum phosphate and intact parathormone emerged as significant predictors for cardiovascular outcomes. Kaplan-Meier curves showed significantly higher cardiovascular mortality rates in CKD patients whose serum magnesium levels were below 2.05 mg/dl.
Conclusions:
This observational cohort study showed that magnesium may be an independent predictor of future cardiovascular outcomes and is the first study demonstrating such a role in etiologically diagnosed CKD patients, across different stages.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease I: Introduction
Serum Studies: Renal Function Tests
